These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3664597)

  • 1. [Therapy of urinary tract infections with ciprofloxacin].
    Horcicková M; Prát V; Matousovic K; Hatala M; Liska M; Milotová Z
    Cas Lek Cesk; 1987 Sep; 126(39):1221-4. PubMed ID: 3664597
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciprofloxacin in the treatment of complicated urinary tract infections.
    Naber K; Sörgel F
    Chemioterapia; 1987 Jun; 6(2 Suppl):522-3. PubMed ID: 3509488
    [No Abstract]   [Full Text] [Related]  

  • 3. [Microbiological evaluation of ciprofloxacin efficacy for treatment of urinary tract infections].
    Kalisz J; Denys A; Szczerba W; Rusinek A; Rogowska-Kalisz A
    Med Dosw Mikrobiol; 1996; 48(3-4):169-75. PubMed ID: 9182138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ciprofloxacin nonsusceptible urinary tract infections with ciprofloxacin.
    Jeffres MN; Shuster JE; Barclay SM
    Ann Pharmacother; 2011 Jun; 45(6):824-5. PubMed ID: 21666093
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of urinary tract infections with ciprofloxacin.
    Martorana G; Giberti C; Pizzorno R; Bonamini A; Oneto F; Curotto A; Soro O
    Clin Ther; 1988; 10(5):516-20. PubMed ID: 2856593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotyping and susceptibility behaviour of pathogens in patients treated with ciprofloxacin.
    Krasemann C; Von Poppel H; Wegge M; Chysky V
    J Chemother; 1989 Jul; 1(4 Suppl):386-8. PubMed ID: 16312452
    [No Abstract]   [Full Text] [Related]  

  • 7. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease.
    Galante D; Esposito S; Barba D; Giusti G
    Chemioterapia; 1986 Oct; 5(5):322-6. PubMed ID: 3791479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin in urinary tract infections.
    Høiby N
    Scand J Infect Dis Suppl; 1989; 60():54-7. PubMed ID: 2667108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3-day therapy of uncomplicated lower urinary tract infections using low-dose ciprofloxacin].
    Prát V; Horcicková M; Matousovic K; Hatala M; Milotová Z
    Cas Lek Cesk; 1988 Nov; 127(48):1492-3. PubMed ID: 3242843
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
    Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
    Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences with tobramycin in polyresistant bacterial urological infections.
    Zarándy B; Varga G
    Ther Hung; 1984; 32(3):123-6. PubMed ID: 6571195
    [No Abstract]   [Full Text] [Related]  

  • 14. Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in the Gaza Strip.
    Astal ZE
    Singapore Med J; 2005 Sep; 46(9):457-60. PubMed ID: 16123829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Temporal pattern of ++resistance to ciprofloxacin in urinary infections].
    Mengoli C; Tonin E; Bertiato G; Rossi L; Peracchi M; Scarin M
    G Ital Chemioter; 1991; 38(1-3):151-2. PubMed ID: 1365574
    [No Abstract]   [Full Text] [Related]  

  • 16. An assessment of ciprofloxacin per os in treatment of serious infections.
    Dellamonica P; Bernard E; Etesse H; Garraffo R; Beziau H
    Chemioterapia; 1987 Jun; 6(2 Suppl):391-4. PubMed ID: 3509456
    [No Abstract]   [Full Text] [Related]  

  • 17. [7-day therapy of urinary tract infection using low-dose ciprofloxacin].
    Prát V; Horcicková M; Matousovic K; Hatala M; Milotová Z
    Cas Lek Cesk; 1988 Mar; 127(13):406-8. PubMed ID: 3365743
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ciprofloxacin in the treatment of chronic urinary tract infections].
    Sozzo E; Patruno P; Mastrangelo F
    Clin Ter; 1988 Mar; 124(5):363-8. PubMed ID: 2974346
    [No Abstract]   [Full Text] [Related]  

  • 19. DUE of ciprofloxacin in the treatment of urinary tract infections in hospitalized patients.
    Dydek GJ; Souney PF; Matthews SJ
    Hosp Formul; 1992 Feb; 27(2):185-91. PubMed ID: 10116716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin (BAY 09867): clinical evaluation in urinary tract infections due to Pseudomonas aeruginosa.
    Guibert JM; Destree DM; Acar JF
    Chemioterapia; 1987 Jun; 6(2 Suppl):524-5. PubMed ID: 3151352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.